(Q37903456)

25 August 2017

1 reference

title

MicroRNA regulation in angiogenesis (English)

1 reference

25 August 2017

1 reference

1 reference

Andrea Caporali

1 reference

25 August 2017

Costanza Emanueli

series ordinal

1 reference

25 August 2017

publication date

14 July 2011

1 reference

25 August 2017

published in

Vascular Pharmacology

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

79-86

1 reference

RNAi therapeutics: principles, prospects and challenges

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Molecular regulation of angiogenesis and lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

7 January 2021

Mammalian mirtron genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-133 controls cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Molecular mechanisms and clinical applications of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

The effect of hyperglycemia and insulin on the replication of cultured human microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

LNA-mediated microRNA silencing in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Changing the logic of therapeutic angiogenesis for ischemic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Therapeutic angiogenesis: translating experimental concepts to medically relevant goals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

An integrated approach for experimental target identification of hypoxia-induced miR-210

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

miR-126 regulates angiogenic signaling and vascular integrity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Angiogenesis in cancer, vascular, rheumatoid and other disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Role of angiogenesis in tumor growth and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Stable knockdown of microRNA in vivo by lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Human RISC couples microRNA biogenesis and posttranscriptional gene silencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Diabetic retinopathy: targeting vasoregression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Hallmarks of Cancer: The Next Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNAs: small RNAs with a big role in gene regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-210 as a novel therapy for treatment of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Roles of oxidative stress and redox regulation in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

miRBase: integrating microRNA annotation and deep-sequencing data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Silencing of microRNAs in vivo with 'antagomirs'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

RNAi and small interfering RNAs in human disease therapeutic applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Prediction of mammalian microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Targeted delivery of antisense inhibitor of miRNA for antiangiogenesis therapy using cRGD-functionalized nanoparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1α expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Nuclear export of microRNA precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

miRiad roles for the miR-17-92 cluster in development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Vascular cell senescence: contribution to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Managing diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNAs modulate the angiogenic properties of HUVECs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

2'-Modified oligonucleotides for antisense therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

microRNA target predictions in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Critical limb ischemia: medical and surgical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNAs as targets for antisense-based therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Desperately seeking microRNA targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

AngiomiRs--key regulators of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Dicer is required for embryonic angiogenesis during mouse development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Controlled delivery of antisense oligonucleotides: a brief review of current strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2011.06.006

10.1016/J.VPH.2011.06.006

7 January 2021

Identifiers

DOI

1 reference

25 August 2017

1 reference